A method for inhibiting hair growth in mammals using compositions containing FP receptor antagonists (e.g., prostaglandin F analogs that are block activation of the FP receptor). The compositions can be applied topically to the skin and/or hair. The compositions can arrest hirsutism or hypertrichosis, reverse hirsutism and hypertrichosis, and further prevent hair growth. These compositions can also be used to protect hair from chemical or radiation-induced alopecia or hair loss. These compositions can also be used to inhibit pigmentation of the hair or skin.

The present disclosure relates to, inter alia, a formulation in a package, the formulation comprises one or more active agents and is co-mingled with a whipping agent prior to being filled under pressure into the package. The whipping agent is added in sufficient amounts to be dispersed in the formulation. The pressurized package is under sufficient pressure suitable to maintain the whipping agent dispersed in the formulation; and the pressurized package is under sufficient pressure to expel the formulation as a whipped formulation upon application of external force on the formulation in the package.

The present disclosure relates to, inter alia, a formulation in a package, the formulation comprises one or more active agents and is co-mingled with a whipping agent prior to being filled under pressure into the package. The whipping agent is added in sufficient amounts to be dispersed in the formulation. The pressurized package is under sufficient pressure suitable to maintain the whipping agent dispersed in the formulation; and the pressurized package is under sufficient pressure to expel the formulation as a whipped formulation upon application of external force on the formulation in the package.

Disclosed are a new composition of lipoamino acids and diols, a process for the preparation thereof, and a cosmetic or pharmaceutical composition resulting therefrom.

Disclosed are a new composition of lipoamino acids and diols, a process for the preparation thereof, and a cosmetic or pharmaceutical composition resulting therefrom.

A composition for healing or improving skin includes a fabric or material impregnated with an oxygen generating material. The fabric may include a first side in contact with the skin for providing oxygen to the skin and a second side between the oxygen generating material and the air surrounding the skin to form a barrier for retaining heat and inhibiting evaporation.

The present invention relates to the use of a mineral blend as cosmetic agent for a wet cosmetic composition, wherein the mineral blend comprises a first component being selected from natural ground calcium carbonate and/or precipitated calcium carbonate, and a second component being a surface-reacted calcium carbonate, as well as to a wet cosmetic composition comprising said mineral blend.

The non-therapeutic cosmetic treatment method includes at least: —applying an active composition including at least niacinamide onto the skin of a subject, and—illuminating the skin using at least one light source emitting at a wavelength of between 620 and 690 nanometres, preferably 660 nanometres, the illumination being carried out before, at the same time as or after the application of the composition. A device is configured for implementing such a method.

The non-therapeutic cosmetic treatment method includes at least: —applying an active composition including at least niacinamide onto the skin of a subject, and—illuminating the skin using at least one light source emitting at a wavelength of between 620 and 690 nanometres, preferably 660 nanometres, the illumination being carried out before, at the same time as or after the application of the composition. A device is configured for implementing such a method.

A dispersion comprises a dispersed phase comprising drops and a continuous aqueous phase, preferably in gel form, wherein the drops comprise a fatty phase comprising at least one lipophilic gelling agent, wherein: the fatty phase has a melting point between 50° C. and 100° C., preferably between 60° C. and 90° C., and, at room temperature and atmospheric pressure, meets the following physicochemical criteria: a hardness (x) of between 2 and 14 N, preferably between 2.5 and 12 N, more preferably between 3 and 9 N, and most preferably between 4 and 6 N; and an adhesiveness (y) greater than or equal to −2 N, and better still, greater than or equal to −1 N, and in particular greater than or equal to −0.6 N; and the dispersion does not comprise amodimethicone.